CYP19A1 and Alzheimer disease: Neuroprotective effects of estrogen, an increased risk of dementia after menopause, and a 19–29% higher prevalence of AD in women compared to men stimulated an investigation into the relationship between estrogen, the estrogen-synthesizing enzyme aromatase, and AD [64, 65, 108, 112, 113].